India
· Delayed Price · Currency is INR Aurobindo Pharma Statistics
Total Valuation
NSE:AUROPHARMA has a market cap or net worth of INR 644.52 billion. The enterprise value is 644.73 billion.
| Market Cap | 644.52B |
| Enterprise Value | 644.73B |
Important Dates
The last earnings date was Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AUROPHARMA has 580.80 million shares outstanding. The number of shares has decreased by -0.53% in one year.
| Current Share Class | 580.80M |
| Shares Outstanding | 580.80M |
| Shares Change (YoY) | -0.53% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 15.31% |
| Owned by Institutions (%) | 33.51% |
| Float | 272.90M |
Valuation Ratios
The trailing PE ratio is 18.55 and the forward PE ratio is 15.93. NSE:AUROPHARMA's PEG ratio is 1.52.
| PE Ratio | 18.55 |
| Forward PE | 15.93 |
| PS Ratio | 2.03 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.27 |
| P/FCF Ratio | 32.94 |
| P/OCF Ratio | 16.42 |
| PEG Ratio | 1.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.81, with an EV/FCF ratio of 32.95.
| EV / Earnings | 18.50 |
| EV / Sales | 2.03 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 13.09 |
| EV / FCF | 32.95 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.85 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.25 |
| Debt / FCF | 4.22 |
| Interest Coverage | 10.84 |
Financial Efficiency
Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 8.00%.
| Return on Equity (ROE) | 11.15% |
| Return on Assets (ROA) | 6.53% |
| Return on Invested Capital (ROIC) | 8.00% |
| Return on Capital Employed (ROCE) | 14.12% |
| Revenue Per Employee | 12.19M |
| Profits Per Employee | 1.34M |
| Employee Count | 26,015 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.28 |
Taxes
In the past 12 months, NSE:AUROPHARMA has paid 15.83 billion in taxes.
| Income Tax | 15.83B |
| Effective Tax Rate | 31.24% |
Stock Price Statistics
The stock price has decreased by -12.08% in the last 52 weeks. The beta is 0.22, so NSE:AUROPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -12.08% |
| 50-Day Moving Average | 1,173.09 |
| 200-Day Moving Average | 1,262.22 |
| Relative Strength Index (RSI) | 35.17 |
| Average Volume (20 Days) | 1,165,599 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AUROPHARMA had revenue of INR 317.24 billion and earned 34.86 billion in profits. Earnings per share was 59.81.
| Revenue | 317.24B |
| Gross Profit | 186.97B |
| Operating Income | 49.56B |
| Pretax Income | 50.66B |
| Net Income | 34.86B |
| EBITDA | 66.05B |
| EBIT | 49.56B |
| Earnings Per Share (EPS) | 59.81 |
Balance Sheet
The company has 82.36 billion in cash and 82.63 billion in debt, giving a net cash position of -273.70 million or -0.47 per share.
| Cash & Cash Equivalents | 82.36B |
| Total Debt | 82.63B |
| Net Cash | -273.70M |
| Net Cash Per Share | -0.47 |
| Equity (Book Value) | 326.47B |
| Book Value Per Share | 562.37 |
| Working Capital | 124.80B |
Cash Flow
In the last 12 months, operating cash flow was 39.25 billion and capital expenditures -19.68 billion, giving a free cash flow of 19.57 billion.
| Operating Cash Flow | 39.25B |
| Capital Expenditures | -19.68B |
| Free Cash Flow | 19.57B |
| FCF Per Share | 33.69 |
Margins
Gross margin is 58.94%, with operating and profit margins of 15.62% and 10.99%.
| Gross Margin | 58.94% |
| Operating Margin | 15.62% |
| Pretax Margin | 15.97% |
| Profit Margin | 10.99% |
| EBITDA Margin | 20.82% |
| EBIT Margin | 15.62% |
| FCF Margin | 6.17% |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.03% |
| Buyback Yield | 0.53% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 5.41% |
| FCF Yield | 3.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |